Work

The tumour suppressor OPCML promotes AXL inactivation by the phosphatase PTPRG in ovarian cancer

Year: 2018

Type: article

Source: EMBO Reports

DOI: 10.15252/embr.201745670

Authors: Jane Antony, Elisa Zanini, Zoe Kelly, Tuan Zea Tan, Evdoxia Karali, Mohammad Alomary, Youngrock Jung, Katherine Nixon, Paula Cunnea, Christina Fotopoulou, Andrew Paterson, Sushmita Roy‐Nawathe, Gordon B Mills, Ruby Yun‐Ju Huang, Jean Paul Thiery, Hani Gabra, Chiara Recchi

Institutions: National University of Singapore, Ovarian Cancer Action, Cancer Science Institute of Singapore, Imperial College London, The University of Texas MD Anderson Cancer Center, National University Health System, Agency for Science, Technology and Research, Institute of Molecular and Cell Biology, AstraZeneca (United Kingdom)

Language: English

Topic: Protein Tyrosine Phosphatases

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Cancer Research UK, Ovarian Cancer Action, National University of Singapore

OpenAlex ID: W2807950784

FWCI: 1.639

Cites: 59

Cited by: 38

Related to: 10